Close Menu
    What's Hot

    China’s Yangtze River Pharmaceutical Group Expands Global Footprint as Quality Drives Growth

    April 29, 2026

    Huawei Unveils the Upgraded Xinghe Intelligent Network Powered by Secure Intelligent Connectivity, Advancing Industrial All Intelligence for Africa

    April 29, 2026

    Children’s Cancer Hospital Egypt Achieves Global Healthcare Accreditation, Advancing Global Competitiveness in International Patient Services

    April 29, 2026
    Facebook X (Twitter) Instagram
    Giza DailyGiza Daily
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Giza DailyGiza Daily
    Home » AfriSummit 2024: African Health Authorities and Industry Leaders Unite to Discuss Pharma Regulations and Innovations
    Featured News

    AfriSummit 2024: African Health Authorities and Industry Leaders Unite to Discuss Pharma Regulations and Innovations

    November 6, 2024
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email VKontakte Telegram WhatsApp

    PharmaReg and MedDevReg AfriSummit Host 80+ Regional and International Speakers Alongside Over 300 Pharmaceutical and Medical Device Professionals

    MENA Newswire: Cairo, Egypt, 06 November 2024 – Prominent healthcare authorities and industry specialists came together for AfriSummit 2024, a vital 4-day hybrid event dedicated to advancing pharmaceutical and medical device regulations along with interactive trainings in eCTD and Pharmacovigilance, all to achieve a healthier Africa. Set at the Grand Nile Tower, the summit attracted more than 300+ delegates and featured over 80 thought leaders from regulatory, legal, manufacturing, and distribution sectors.

    The Egyptian Drug Authority, which was one of the main authorities present at AfriSummit 2024, had Dr. Rasha Ziada, the EDA Chairman Assistant for Professional Development and Capacity Building Affairs, conduct the opening where she mentioned “Achievement of WHO maturity Level 3 not just a milestone but a responsibility on us, we are responsible in supporting other African countries to reach the same level.” Dr. Rasha has also expressed that “As a regulatory authority, our mission extends beyond safeguarding and overseeing the use of medicines at the national level; it also reaches across Africa.”

    AfriSummit 2024 highlighted innovative approaches to drug trials and approvals, enriched by workshops like eCTD Training and Pharmacovigilance. Dr. Mona Al Moussli, Chairman of AfriSummit, stated, “This year’s AfriSummit was truly extravagant, featuring a remarkable participation of industry leaders. Their insightful presentations underscored the crucial need for harmonization in regulatory practices across Africa, paving the way for a more integrated healthcare landscape.”

    Key dignitaries presented their regulatory insights, underscoring the event’s importance in enhancing compliance and improving healthcare standards. In addition, AfriSummit 2024 was honourably attended by ambassadors and ministers and diplomats from across the African continent.

    Dr. Najiba Al Shezawy, Co-Chairman of AfriSummit, expressed her gratitude for the participation of various African authorities this year, stating, “We deeply appreciate the contributions of all participating African NRAs, whose insights and engagement are crucial for strengthening our regulatory frameworks and fostering collaboration across the continent.”

    Attendees actively engaged in comprehensive roundtable discussions with representatives from key healthcare authorities, fostering an environment of collaboration, which aimed at addressing the regulatory challenges and opportunities facing the pharmaceutical and healthcare sectors.

    The summit affirmed its status as the leading annual gathering for the regulatory affairs in pharmaceutical, medical device and healthcare sectors across Africa, of which are experiencing significant growth.

    As AfriSummit 2024 wrapped up, it sent a powerful message of collaboration and dedication to enhancing healthcare standards across the continent. The event reinforced its position as a crucial platform for fostering cooperation among stakeholders and driving transformative change in the pharmaceutical landscape.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email VKontakte WhatsApp
    Previous ArticleWHO report highlights top 17 pathogens in need of new vaccines
    Next Article Burjeel Holdings sees 14% revenue rise, hits AED 1.3 billion in Q3

    Related Posts

    AI Match Predictions, Live Table Projections, and More: Tribuna.com Releases Full Feature Breakdown for the 2026 FIFA World Cup

    April 17, 2026

    Bitget Launches New Pre-IPO Product With SpaceX as First Listing

    April 15, 2026

    Truecaller Crosses 500 Million Users: Sets a New Global Standard for Trusted Communication

    March 31, 2026
    Editor's Pick

    UAE India dialogue turns to security and energy

    April 27, 2026

    UAE and Mauritania presidents deepen bilateral ties

    April 27, 2026

    UAE and Mauritania presidents deepen bilateral ties

    April 27, 2026

    UAE mediation helps Russia and Ukraine swap 386 captives

    April 25, 2026

    Bilateral ties and regional security reviewed in UAE Dutch talks

    April 24, 2026

    Syria gets US$225 million World Bank water health aid

    April 24, 2026

    Dnata invests A$32 million in Western Sydney cargo hub

    April 23, 2026
    © 2026 Giza Daily | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.